Yıl: 2021 Cilt: 43 Sayı: 6 Sayfa Aralığı: 541 - 547 Metin Dili: İngilizce DOI: 10.14744/etd.2021.75983 İndeks Tarihi: 18-02-2022

The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens

Öz:
Objective: Appropriate selection of the type of blood specimen tube employed is of great importance to the accurate and reliable measurement of oxidative stress biomarkers. This study examined the effect of specimen variety on measurement results using serum and plasma samples obtained from blood tubes with six different contents for measuring ischemia-modified albumin (IMA), total oxidant status (TOS), and total antioxidant status (TAS). Materials and Methods: Ischemia-modified albumin, TOS, and TAS levels were assayed in serum and plasma specimens obtained from blood collected from 16 volunteers and placed into serum collection tubes, plain tubes, and anticoagulant tubes containing dipotassium EDTA, trisodium citrate, lithium heparin, and sodium fluoride/disodium EDTA (NaF/Na2EDTA). IMA was measured using the Bar-Or method, and TOS and TAS were measured using TOS and TAS assay kits, respectively. Total albumin assay was performed using a Beckman Coulter AU5800 autoanalyzer. Results: In all tubes, IMA, IMA/albumin ratio, TOS, TAS, and oxidative stress index values were compared, and all these parameters were found to be statistically significant between six different tubes (p=0.0001). Ischemia-modified albumin and TOS measurements in plasma specimens obtained from tubes containing dipotassium EDTA and NaF/Na2EDTA differed significantly from the results of the other specimens. Conclusion: We conclude that IMA and TOS cannot be measured from blood specimens with dipotassium EDTA and NaF/ Na2EDTA. However, TAS can be determined in all specimen types. The selection of the specimen type to be used in the measurement of IMA, TOS, and TAS is of great importance and now requires standardization.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Vassalle C, Maltinti M, Sabatino L. Targeting oxidative stress for disease prevention and therapy: where do we stand, and where do we go from here. Molecules 2020; 25(11): 2653.
  • 2. Hakkoymaz H, Nazik S, Seyithanoğlu M, Güler Ö, Şahin AR, Cengiz E, et al. The value of ischemia-modified albumin and oxidative stress markers in the diagnosis of acute appendicitis in adults. Am J Emerg Med 2019; 37(11): 2097–101.
  • 3. Mentese A, Güven S, Demir S, Sümer A, Yaman SÖ, Alver A, et al. Circulating parameters of oxidative stress and hypoxia in normal pregnancy and HELLP syndrome. Adv Clin Exp Med 2018; 27(11): 1567–72.
  • 4. Kazaz IO, Mentese A, Demir S, Kerimoglu G, Colak F, Bodur A, et al. Berberine inhibits the ischemia-reperfusion induced testicular injury through decreasing oxidative stress. Am J Emerg Med 2020; 38(1): 33–7.
  • 5. Guven S, Kart C, Guvendag Guven ES, Cetin EC, Menteşe A. Is the measurement of serum ischemia-modified albumin the best test to diagnose ovarian torsion? Gynecol Obstet Invest 2015; 79(4): 269–75.
  • 6. Dilek F, Ozkaya E, Kocyigit A, Yazici M, Kesgin S, Gedik AH, et al. Effect of montelukast monotherapy on oxidative stress parameters and DNA damage in children with asthma. Int Arch Allergy Immunol 2015; 167(2): 119–26.
  • 7. Bukhari SA, Rajoka MI, Ibrahim Z, Jalal F, Rana SM, Nagra SA. Oxidative stress elevated DNA damage and homocysteine level in normal pregnant women in a segment of Pakistani population. Mol Biol Rep 2011; 38(4): 2703–10.
  • 8. Bowen RA, Remaley AT. Interferences from blood collection tube components on clinical chemistry assays. Biochem Med (Zagreb) 2014; 24(1): 31–44.
  • 9. Sulaiman RA, Cornes MP, Whitehead SJ, Othonos N, Ford C, Gama R. Effect of order of draw of blood samples during phlebotomy on routine biochemistry results. J Clin Pathol 2011; 64(11): 1019–20.
  • 10. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000; 19(4): 311–5.
  • 11. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38(12): 1103–11.
  • 12. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37(4): 277–85.
  • 13. Aycicek A, Erel O, Kocyigit A. Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 2005; 47(6): 635–9.
  • 14. Dogan D, Ocal N, Aydogan M, Tasci C, Arslan Y, Tapan S, et al. Assessment of the role of serum ischemia-modified albumin in obstructive sleep apnea in comparison with interleukin-6. Postgrad Med 2016; 128(6): 603–8.
  • 15. Dahiya K, Kulshrestha MR, Bansal P, Ghalaut VS, Kulshrestha R, Dahiya P, et al. Evaluation of cord blood ischemia modified albumin in normal pregnancies and pre-eclampsia. Hypertens Pregnancy 2015; 34(2): 204–8.
  • 16. Hazini A, Cemek M, Işıldak İ, Alpdağtaş S, Önül A, Şenel Ü, et al. Investigation of ischemia modified albumin, oxidant and antioxidant markers in acute myocardial infarction. Postepy Kardiol Interwencyjnej 2015; 11(4): 298–303.
  • 17. D’Souza JM, D’Souza RP, Vijin VF, Shetty A, Arunachalam C, Pai VR, et al. High predictive ability of glycated hemoglobin on comparison with oxidative stress markers in assessment of chronic vascular complications in type 2 diabetes mellitus. Scand J Clin Lab Invest 2016; 76(1): 51–7.
  • 18. De la Salle B. Pre- and postanalytical errors in haematology. Int J Lab Hematol 2019; 41(Suppl 1): 170–6.
  • 19. Atik İ, Kozacı N, Beydilli İ, Avcı M, Ellidağ H, Keşaplı M. Investigation of oxidant and antioxidant levels in patients with acute stroke in the emergency service. Am J Emerg Med 2016; 34(12): 2379–83.
  • 20. Işik S, Kılıç S, Öğretmen Z, Çakır DÜ, Türkön H, Cevizci S, et al. The correlation between the psoriasis area severity index and ischemia-modified albumin, mean platelet volume levels in patients with psoriasis. Postepy Dermatol Alergol 2016; 33(4): 290–3.
  • 21. Toffaletti JG, Wildermann RF. The effects of heparin anticoagulants and fill volume in blood gas syringes on ionized calcium and magnesium measurements. Clin Chim Acta 2001; 304(1-2): 147–51.
  • 22. Zaninotto M, Mion M, Altinier S, Forni M, Plebani M. Quality specifications for biochemical markers of myocardial injury. Clin Chim Acta 2004; 346(1): 65–72.
APA Erdem M, KARAHAN S, Menteşe A, OZER YAMAN S, Demir S (2021). The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. , 541 - 547. 10.14744/etd.2021.75983
Chicago Erdem Mehmet,KARAHAN SÜLEYMAN CANER,Menteşe Ahmet,OZER YAMAN SERAP,Demir Selim The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. (2021): 541 - 547. 10.14744/etd.2021.75983
MLA Erdem Mehmet,KARAHAN SÜLEYMAN CANER,Menteşe Ahmet,OZER YAMAN SERAP,Demir Selim The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. , 2021, ss.541 - 547. 10.14744/etd.2021.75983
AMA Erdem M,KARAHAN S,Menteşe A,OZER YAMAN S,Demir S The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. . 2021; 541 - 547. 10.14744/etd.2021.75983
Vancouver Erdem M,KARAHAN S,Menteşe A,OZER YAMAN S,Demir S The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. . 2021; 541 - 547. 10.14744/etd.2021.75983
IEEE Erdem M,KARAHAN S,Menteşe A,OZER YAMAN S,Demir S "The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens." , ss.541 - 547, 2021. 10.14744/etd.2021.75983
ISNAD Erdem, Mehmet vd. "The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens". (2021), 541-547. https://doi.org/10.14744/etd.2021.75983
APA Erdem M, KARAHAN S, Menteşe A, OZER YAMAN S, Demir S (2021). The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. Erciyes Medical Journal, 43(6), 541 - 547. 10.14744/etd.2021.75983
Chicago Erdem Mehmet,KARAHAN SÜLEYMAN CANER,Menteşe Ahmet,OZER YAMAN SERAP,Demir Selim The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. Erciyes Medical Journal 43, no.6 (2021): 541 - 547. 10.14744/etd.2021.75983
MLA Erdem Mehmet,KARAHAN SÜLEYMAN CANER,Menteşe Ahmet,OZER YAMAN SERAP,Demir Selim The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. Erciyes Medical Journal, vol.43, no.6, 2021, ss.541 - 547. 10.14744/etd.2021.75983
AMA Erdem M,KARAHAN S,Menteşe A,OZER YAMAN S,Demir S The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. Erciyes Medical Journal. 2021; 43(6): 541 - 547. 10.14744/etd.2021.75983
Vancouver Erdem M,KARAHAN S,Menteşe A,OZER YAMAN S,Demir S The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens. Erciyes Medical Journal. 2021; 43(6): 541 - 547. 10.14744/etd.2021.75983
IEEE Erdem M,KARAHAN S,Menteşe A,OZER YAMAN S,Demir S "The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens." Erciyes Medical Journal, 43, ss.541 - 547, 2021. 10.14744/etd.2021.75983
ISNAD Erdem, Mehmet vd. "The Assessment of Oxidative Stress Biomarkers in Different Serum and Plasma Specimens". Erciyes Medical Journal 43/6 (2021), 541-547. https://doi.org/10.14744/etd.2021.75983